The oxygen concentrators market is projected to reach USD 1.71 billion by 2030 from USD 1.27 billion in 2025, at a CAGR of 6.1% during the forecast period.
Technological advancements are crucial in driving growth in the oxygen concentrators market. Modern units are more compact, lightweight, energy-efficient, and user-friendly. Innovations like pulse dose technology deliver oxygen only during inhalation to conserve it and extend battery life, especially in portable models. New devices feature silent operation, digital displays, alarms, connectivity for remote monitoring, and support both pulse and continuous flow modes. Portable concentrators with long-lasting batteries are popular among active users and travelers, some FAA-approved for flights. IoT integration enables real-time data sharing with healthcare providers, enhancing patient compliance. AI algorithms optimize oxygen delivery based on respiratory patterns. These innovations improve convenience, patient quality of life, and broaden application scope, fueling market growth as adoption increases.
Based on type, the market is divided into portable and stationary oxygen concentrators. In 2024, the portable oxygen concentrator segment holds the largest share of the global oxygen concentrator market. The increasing global geriatric population is a key factor driving demand for portable oxygen concentrators (POCs). Older adults are more vulnerable to chronic respiratory conditions such as COPD, pulmonary fibrosis, and hypoxia related to heart failure. Mobility challenges in old age make POCs a practical solution, allowing elderly patients to receive oxygen therapy without being restricted to a stationary device. Being able to carry oxygen support while moving around at home, outdoors, or during travel greatly improves their independence and quality of life. As the aging population continues to grow - especially in developed areas like North America, Europe, and parts of Asia - the demand for compact, dependable, and easy-to-use oxygen devices like POCs steadily increases, strengthening their market dominance.
Based on end users, the OC market has been categorized into home care settings, hospitals and clinics, and ambulatory surgical centers & physician offices. In 2024, home care settings held the largest share in the OC market. The increasing global elderly population is a key factor driving demand in the home care segment of the oxygen concentrators market. Older adults are more vulnerable to chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), emphysema, and age-related decline in lung function.
These conditions often require long-term oxygen therapy, which is increasingly managed at home due to its convenience and lower cost. Additionally, elderly patients often face mobility issues, making frequent hospital visits difficult. Home-based oxygen concentrators provide a safe and accessible solution, allowing independence while maintaining continuous respiratory support. Countries like Japan, Germany, Italy, and the US - with rapidly aging populations - are seeing a particularly high adoption of oxygen concentrators in home care settings.
North America is expected to hold the largest share of the OC market during the forecast period. North America, especially the US and Canada, has highly developed healthcare systems equipped with modern diagnostic and therapeutic technologies. The region's hospitals, clinics, and outpatient centers have widespread access to oxygen delivery equipment, including concentrators.
Additionally, structured healthcare policies, integrated insurance networks, and streamlined procurement channels ensure the smooth availability and distribution of these devices. Patients benefit from faster diagnoses and prompt initiation of oxygen therapy. Home care support systems are also advanced, allowing a safe transition from hospital to home with continuous oxygen support. These favorable conditions improve the accessibility and use of oxygen concentrators, especially for chronic patients, and reinforce North America's leadership position in the global oxygen concentrators market.
Technological advancements are crucial in driving growth in the oxygen concentrators market. Modern units are more compact, lightweight, energy-efficient, and user-friendly. Innovations like pulse dose technology deliver oxygen only during inhalation to conserve it and extend battery life, especially in portable models. New devices feature silent operation, digital displays, alarms, connectivity for remote monitoring, and support both pulse and continuous flow modes. Portable concentrators with long-lasting batteries are popular among active users and travelers, some FAA-approved for flights. IoT integration enables real-time data sharing with healthcare providers, enhancing patient compliance. AI algorithms optimize oxygen delivery based on respiratory patterns. These innovations improve convenience, patient quality of life, and broaden application scope, fueling market growth as adoption increases.
Based on type, the market is divided into portable and stationary oxygen concentrators. In 2024, the portable oxygen concentrator segment holds the largest share of the global oxygen concentrator market. The increasing global geriatric population is a key factor driving demand for portable oxygen concentrators (POCs). Older adults are more vulnerable to chronic respiratory conditions such as COPD, pulmonary fibrosis, and hypoxia related to heart failure. Mobility challenges in old age make POCs a practical solution, allowing elderly patients to receive oxygen therapy without being restricted to a stationary device. Being able to carry oxygen support while moving around at home, outdoors, or during travel greatly improves their independence and quality of life. As the aging population continues to grow - especially in developed areas like North America, Europe, and parts of Asia - the demand for compact, dependable, and easy-to-use oxygen devices like POCs steadily increases, strengthening their market dominance.
Based on end users, the OC market has been categorized into home care settings, hospitals and clinics, and ambulatory surgical centers & physician offices. In 2024, home care settings held the largest share in the OC market. The increasing global elderly population is a key factor driving demand in the home care segment of the oxygen concentrators market. Older adults are more vulnerable to chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), emphysema, and age-related decline in lung function.
These conditions often require long-term oxygen therapy, which is increasingly managed at home due to its convenience and lower cost. Additionally, elderly patients often face mobility issues, making frequent hospital visits difficult. Home-based oxygen concentrators provide a safe and accessible solution, allowing independence while maintaining continuous respiratory support. Countries like Japan, Germany, Italy, and the US - with rapidly aging populations - are seeing a particularly high adoption of oxygen concentrators in home care settings.
North America is expected to hold the largest share of the OC market during the forecast period. North America, especially the US and Canada, has highly developed healthcare systems equipped with modern diagnostic and therapeutic technologies. The region's hospitals, clinics, and outpatient centers have widespread access to oxygen delivery equipment, including concentrators.
Additionally, structured healthcare policies, integrated insurance networks, and streamlined procurement channels ensure the smooth availability and distribution of these devices. Patients benefit from faster diagnoses and prompt initiation of oxygen therapy. Home care support systems are also advanced, allowing a safe transition from hospital to home with continuous oxygen support. These favorable conditions improve the accessibility and use of oxygen concentrators, especially for chronic patients, and reinforce North America's leadership position in the global oxygen concentrators market.
A breakdown of the primary participants (supply-side) for the oxygen concentrators market referred to in this report is provided below:
- By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28%
- By Designation: C-level: 26%, Director Level: 35%, and Others: 39%
- By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%
Research Coverage
The report assesses the oxygen concentrators market and estimates its size and future growth potential across various segments, including type, technology, flow rate, application, end user, and region. It also provides a competitive analysis of the leading companies in the market, along with their profiles, product offerings, recent developments, and key strategies.Reasons to Buy the Report
The report will help market leaders and new entrants by providing data on the closest estimates of revenue for the overall oxygen concentrators market and its subsegments. It will aid stakeholders in understanding the competitive landscape and gaining insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp market trends and offers data on key drivers, obstacles, challenges, and opportunities within the market.This report provides insights into the following points:
- Analysis of key drivers (rising prevalence of respiratory diseases, growing geriatric population, increasing demand for home healthcare, government initiatives and reimbursement support, technological advancements), restraints (high cost of advanced oxygen concentrators, product recalls or malfunctions), opportunities (integration of digital health features, development of solar-powered or battery-efficient models) and challenges (lack of awareness and diagnosis, competition from low-cost alternatives)
- Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global OC market
- Market Development: Thorough knowledge and analysis of the profitable rising markets by type, technology, flowrate, application, end user, and region
- Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global OC market
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global OC market
Table of Contents
1 Introduction
2 Research Methodology
4 Premium Insights
5 Market Overview
6 Oxygen Concentrators Market, by Type
7 Oxygen Concentrators Market, by Technology
8 Oxygen Concentrators Market, by Flowrate
9 Oxygen Concentrators Market, by Application
10 Oxygen Concentrators Market, by End-user
11 Oxygen Concentrators Market, by Region
12 Competitive Landscape
13 Company Profiles
14 Appendix
List of Tables
List of Figures
Companies Mentioned
- Koninklijke Philips N.V.
- Inogen, Inc.
- Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
- Caire Inc.
- Drive Devilbiss Healthcare
- Teijin Limited
- Daikin Industries, Ltd.
- Esab Corporation (Gce Group)
- React Health
- Precision Medical, Inc.
- Nidek Medical Products, Inc.
- O2 Concepts, LLC
- Bpl Medical Technologies
- Besco
- Oxus
- Foshan Keyhub Electronic Industries Co. Ltd
- Longfian Scitech Co. Ltd.
- Shenyang Canta Medical Tech. Co. Ltd.
- Belluscura
- Hoyo Scitech Co. Ltd.
- Hacenor Solutions
- Xnuo International Group (USA) Holdings
- Oxymed
- Kalstein
- Ess Pee Enterprises
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 246 |
| Published | September 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 1.27 Billion |
| Forecasted Market Value ( USD | $ 1.71 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
